LAN, ERMING – Trademark Portfolio

Entity Type: 01

LAN, ERMING holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ONLYOU and DRIHOII. The owner is based in SHANXI PROVINCE.

NO. 101, GUIJIAYAO, SHANGGUAN TOWN, DAI

COUNTY

SHANXI PROVINCE 034200 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DRIHOII
DRIHOII
Registered 2020
ONLYOU
ONLYOU
Registered 2020

Trademark Classifications

LAN, ERMING's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does LAN, ERMING have?

LAN, ERMING has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does LAN, ERMING file in?

LAN, ERMING files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are LAN, ERMING's most well-known trademarks?

LAN, ERMING's registered trademark portfolio includes well-known marks such as ONLYOU and DRIHOII. These are among 2 currently registered trademarks in the portfolio.

What is LAN, ERMING's trademark registration success rate?

LAN, ERMING has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.